<DOC>
	<DOCNO>NCT01943500</DOCNO>
	<brief_summary>Objective : To test sensitivity proprietary novel filtration device design capture concentrate circulate tumor cell ( CTCs ) .</brief_summary>
	<brief_title>Collection Blood Specimens Circulating Tumor Cell Analysis</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Age &gt; 18 year age Written inform consent obtain Confirmed diagnosis stage 24 breast , prostate , colorectal cancer , ( OR ) prior history cancer Stage 24 treatment naive , metastatic , secondary , recurrent cancer patient Able undergo blood collection prior initiation chemotherapy treatment , ( OR ) able provide blood sample subject noncancer control subject Patients unable understand research protocol and/or provide inform consent . Patients known immunodeficiency , pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Colorectal cancer</keyword>
	<keyword>Circulating tumor cell ( CTC )</keyword>
</DOC>